← Back to Clinical Trials
Recruiting NCT06587022
Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors
Trial Parameters
Condition Spinal Tumor
Sponsor Peking University Third Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age 18 Years
Max Age 90 Years
Start Date 2017-01-01
Completion 2026-12-30
Interventions
Target volume delineation
Brief Summary
The purpose of this study was to compare efficacy and side effects of two target delineation methods for stereotactic radiotherapy of metastatic spinal tumors.
Eligibility Criteria
Inclusion Criteria: * Patients with spinal metastases or primary tumors receiving stereotactic radiotherapy; * Patients with sufficent pre-treatment imaging data * Patients who can cooperate with imaging review and follow-up after radiotherapy. Exclusion Criteria: * Patients with an expected survival of less than 3 months; * Patients with second-course radiotherapy; * Patients with physical conditions that cannot tolerate stereotactic radiotherapy; * Patients with extensive spinal metastasis and no local therapeutic value